Experimental study reveals electrophilic μ-1,2-peroxo Fe III complex formation in diiron systems, suggesting new oxidation pathways.
Non-heme diiron enzymes (NHFe₂) activate O₂ by reaction with a reduced FeIIFeII form, providing peroxo FeIIIFeIII intermediates that are capable of electrophilic substrate oxidations. In contrast, the peroxo FeIIIFeIII model complexes reported so far do not show this reactivity. Using a bis(tetradentate) dinucleating ligand, we report here an electrophilic {FeIII(μ-1,2-peroxo)(μ-O)FeIII} complex that was generated in a manner analogous to NHFe₂ in situ by the reaction of the {FeII(μ-OH)₂FeII} precursor with O₂ in the presence of a base and characterized by cryospray-ionization mass spectrometry and UV-vis-NIR, Mössbauer, resonance Raman, and X-ray absorption spectroscopies in conjunction with DFT calculations. In the absence of a base, an end-on hydroperoxo intermediate {FeIII(μ-O)FeIII(OOH)} is formed, which reacts slowly with the weak base NEt₃ to give {FeIII(μ-1,2-peroxo)(μ-O)FeIII} without observable intermediates, while the strong base 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) deprotonates the end-on hydroperoxo in a first fast step to form a side-on peroxo that converts in a second slower step to the μ-1,2-peroxo bridge. The {FeIII(μ-1,2-peroxo)(μ-O)FeIII} complex exhibits unprecedented electrophilic reactivity in oxygen atom transfer with PPh₃ and hydrogen atom transfer with 9,10-dihydroanthracene (DHA) and benzyl alcohol. This reactivity is discussed in terms of the ligand's electron-donating properties.
No takes yet. Share an insight, caveat, or question.
Jansen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: